ISRCTN20410413已完成不适用
Reduction of Early Mortality among HIV-infected Subjects sTarting AntiRetroviral Therapy (REMSTART) in Zambia and Tanzania with CD4 count <200 cells per microlitre: a randomised trial involving home support and routine screening for cryptococcal meningitis
ondon School of Hygiene and Tropical Medicine (UK)0 个研究点目标入组 2,500 人开始时间: 2011年11月9日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 05/07/2013:
- •1. CD4 < 200 cells /µl
- •2. Adult: = 18 years
- •3. Antiretroviral na?ve (as reported by the patient)
- •4. Planning to remain in the study area for about six months (as reported by the patient)
- •Previous inclusion criteria:
- •1. CD4 < 100 cells /µl
- •2. Adult: = 18 years
- •3. Antiretroviral na?ve (as reported by the patient)
- •4. Planning to remain in the study area for about six months (as reported by the patient)
排除标准
- •1. Requiring immediate in-patient care/admission
- •2. Living outside the catchment population of the hospital
研究者
相似试验
尚未招募
3 期
REDUCING MORTALITY IN ADULTS WITH ADVANCED HIV DISEASE (REVIVE)PACTR202302799565020Population Health Research Institute8,000
已完成
3 期
Reduction of early mortality in HIV-infected African adults and children starting antiretroviral therapyHuman Immunodeficiency Virus (HIV)Infections and InfestationsHuman immunodeficiency virus [HIV] diseaseISRCTN43622374Medical Research Council (UK)1,805
已完成
不适用
Prevention of late presentation of an HIV infectioHIV prevalentieHIV prevalenceNL-OMON22242Prof.dr. A. Verbon, Dr. TEMS de Vries-Sluijs, Dhr. G.P.M. Luiken; Erasmus MC, RotterdamProf.dr. J.M. Prins; AMC, AmterdamDr. J.G. den Hollander; Maasstad zh, Rotterdam4,500
已完成
不适用
Prevention of late presentation of an HIV infectioAIDSHIV10047438NL-OMON40685Erasmus MC, Universitair Medisch Centrum Rotterdam4,000
已完成
不适用
Measuring HIV-related mortality during surveys in AfricaISRCTN15197669ational Institute of Allergy and Infectious Diseases (NIAID)535